← Back to headlines
Travere Therapeutics Positioned for Long-Term Growth in Rare Disease Market
Travere Therapeutics, Inc. (TVTX) is seen as well-positioned for long-term growth within the rare disease market.
18 Feb, 06:10 — 18 Feb, 06:10
Read at source (1 outlet)
Related Stories
Analyst Recommends Verizon and T-Mobile for Anxious Investors
13m ago
Japan's Ministry of Finance Projects Soaring National Debt Costs by 2029
13m ago
Howmet Aerospace Sees Strong Institutional Inflows
13m ago
Stock Index Futures Climb as AI Jitters Ease, FOMC Minutes and U.S. Economic Data in Focus
13m ago